Ekso Bionics Holding (EKSO) 1.9400 $EKSO
Ekso Bionics Holdings elects Amy Wendell to board
M2 - Wed Apr 08, 7:05AM CDT
Robotic medical company Ekso Bionics Holdings (OTCBB:EKSO) disclosed on Wednesday the addition of Amy Wendell to its board of directors.
Amy Wendell Joins Ekso Bionics Board of Directors
GlobeNewswire - Wed Apr 08, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) today announced that Amy Wendell, former Senior Vice President, Strategy and Business Development of Covidien, global health care products company and manufacturer of medical devices and supplies, has been elected to Ekso Bionics' board of directors.
Ekso Bionics' Rehab Vertical Gets Healthy With Some Big News From The U.K.
Dallas Salazar - at Seeking Alpha - Mon Apr 06, 6:55AM CDT
RWLK: 13.60 (+0.08)
Pivotal Legal Case Settlement Includes Ekso Bionics Ekso GT(TM) Robotic Exoskeleton
Thomson Reuters ONE - Tue Mar 31, 1:00AM CDT
CANARY WHARF, LONDON, March 31, 2015 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that Dale Messenger, who was left paralyzed with an L1 incomplete spinal cord injury after suffering a gunshot wound, settled a long running case at the High Court in the United Kingdom. His damages settlement includes, among other items, the purchase cost of an Ekso Bionics Ekso GT robotic exoskeleton, its replacement over the years, and related utilization costs.
Ekso Bionics: Well-Positioned In A Thriving Industry
Simple Investment Ideas - at Seeking Alpha - Fri Mar 27, 8:07AM CDT
Ekso Bionics: Sales Progress And Improved Financials
Dallas Salazar - at Seeking Alpha - Wed Mar 18, 3:11PM CDT
Ekso Bionics Holdings reports Q4 results
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:15PM CDT
Ekso Bionics Reports Fourth Quarter and 2014 Financial Results
GlobeNewswire - Tue Mar 17, 3:05PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the quarter and year ended December 31, 2014, as well as recent highlights.
Ekso Bionics(TM) to Host Fourth Quarter and Year End Financial Results Conference Call on Tuesday, March 17th, 2015
GlobeNewswire - Wed Mar 11, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company today announced that it will host a conference call and audio webcast to discuss fourth quarter and year end results, as well as provide a general business update, on Tuesday, March 17th, 2015 at 4:30pm ET.
IPO Lockup Expiration: ReWalk Robotics Ltd.
Don Dion - at Seeking Alpha - Tue Mar 03, 7:18AM CST
PH: 120.53 (+0.76), RWLK: 13.60 (+0.08)
Exoskeletons Becoming Science Fact With Potential Opportunity For Early Investors
Investment Capitalist - at Seeking Alpha - Fri Feb 13, 11:37AM CST
ISRG: 530.36 (+17.27), GOOG: 540.01 (-0.77)
ReWalk Robotics Has Been One Painful Science Experiment For Investors
Dallas Salazar - at Seeking Alpha - Thu Feb 12, 11:09PM CST
RWLK: 13.60 (+0.08)
Research and Markets: Global Exoskeleton System Market 2015-2019: Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics
Business Wire - Wed Feb 11, 3:01PM CST
Research and Markets (http://www.researchandmarkets.com/research/rh4pd7/global) has announced the addition of the "Global Exoskeleton System Market 2015-2019" report to their offering.
RWLK: 13.60 (+0.08)
Global Exoskeleton System Market 2015-2019: Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics
M2 - Wed Feb 11, 2:32PM CST
Research and Markets (http://www.researchandmarkets.com/research/5n9pd6/global) has announced the addition of the "Global Exoskeleton System Market 2015-2019" report to their offering. The Global Exoskeleton System market to grow at a CAGR of 72.51% over the period 2014-2019 An exoskeleton system is a man-machine system that combines human intelligence and machine power, thereby enabling individuals to gain super strength to walk or move. It is widely used across the Healthcare sector for rehabilitation. In rehabilitation centers, an exoskeleton system helps in tendon therapy and exercise. Individuals suffering from hip or knee conditions can use exoskeleton system to prevent common accidents such as slipping or to walk again. These systems are also used across the Military and Industrial sectors. One of the major trends in the market is the development of an exoskeleton-mounted computer system for soldiers. The US military has awarded several exoskeleton R&D project contracts to various robotic companies and research institutes in the Americas. According to the report, the rise in orthopedic disorders is a major growth driver for the market. The use of exoskeletons by people with orthopedic disorders helps improve their mobility because they put the body in an upright position, thereby bringing back their self-esteem. Further, the report states that one of the major challenges that the market faces is the high price of exoskeleton systems, which means that they are not affordable for many paralyzed individuals in the developing countries. Several paralyzed individuals in the developing countries cannot afford to buy exoskeletons because insurance companies do not provide funds to buy such devices. Key Vendors - Cyberdyne - Ekso Bionics - ReWalk Robotics - Rex Bionics Other Prominent Vendors - Berkley Robotics - Focal Meditech - Hocoma - Honda - Interactive Motion Technologies - LockHeed Martin - Myomo - Parker Hannafin - Raytheon Sarcos For more information visit http://www.researchandmarkets.com/research/5n9pd6/global
RTN: 109.96 (-0.05), RWLK: 13.60 (+0.08)
Global Exoskeleton System Market 2015-2019 with Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics Dominating
PR Newswire Europe - Wed Feb 11, 12:32PM CST
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets
RWLK: 13.60 (+0.08)
Ekso Bionics(TM) Launches Multi Center Study With Leading European Hospitals
GlobeNewswire - Thu Jan 29, 6:00AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that nine leading centers in Europe including SPZ Notwill in Switzerland, Institut Guttmann in Spain and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark (now part of Rigshospitalet and Glostrup Hospital), are participating in a clinical study to include close to 70 participants. The study will examine how Ekso GT may improve general outcomes as well as reduce secondary complications, such as pain and bowel and bladder dysfunction, commonly associated with spinal cord injury (SCI), and is expected to run for 30 months with early findings expected next year.
Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project
GlobeNewswire - Thu Jan 22, 6:09AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that their leading work on the first phase of the TALOS project resulted in a grant to expand their involvement into the second phase of the project. United States Special Operation Command (SOCOM) announced last year that it was working to create a wearable uniform, which provides superhuman capabilities with superior mobility and protection, for their Special Operations Forces. This project involves four phases, with the second phase to be delivered in the latter part of 2015. With the second phase of the project, this contract marks over $35 million in total third party funded development work done by the Ekso Bionics engineering team.
Research and Markets: Global Rehabilitation Robotics Market 2015-2019 with AlterG, Ekso Bionics, Hocoma & Interactive Motion Technologies Dominating
Business Wire - Fri Jan 09, 5:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/6flkmd/global) has announced the addition of the "Global Rehabilitation Robotics Market 2015-2019" report to their offering.
Global Rehabilitation Robotics Market 2015-2019 with AlterG, Ekso Bionics, Hocoma & Interactive Motion Technologies Dominating
M2 - Fri Jan 09, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/5l5dxp/global) has announced the addition of the "Global Rehabilitation Robotics Market 2015-2019" report to their offering. The analysts forecast the Global Rehabilitation Robotics market to grow at a CAGR of 24.27% over the period 2014-2019 Rehabilitation robots play an important role in improving a patient's functional recovery. Stroke is a global problem, and it is the main cause of disability in most western countries. Rehabilitation robots are used as therapy aids and the potential benefit of robotic therapy is that it can treat a larger number of patients under the supervision of a single therapist. In other words, rehabilitation robots work as a therapeutic tool for optimizing and maximizing clinical effectiveness of a therapy. One major trend emerging in this market is the rise in the number of well-equipped private hospitals with advanced facilities. Private hospitals are well-equipped and provide more advanced facilities compared to public hospitals. In addition, patients can avail the best treatment in private hospitals. According to the report, one of the major drivers of this market is the increase in incidence of orthopedic disorders that cause severe long-term pain and physical disability. Orthopedic disorders affect hundreds of millions of people worldwide. Further, the report states that one of the main challenges in the market is the high cost of rehabilitation robots, which forces patients to opt for normal therapeutic exercises. Moreover, governments are providing decreased reimbursements for rehabilitation robotic therapy. The Global Rehabilitation Robotics market can be segmented into the following based on products: - Prosthetics Robotics - Orthotics Robotics - Therapeutic Robots - Exoskeleton Robotic Systems Key Vendors - AlterG - Ekso Bionics - Hocoma - Interactive Motion Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/5l5dxp/global
Ekso Bionics Holdings elects Amy Wendell to board
M2 - Wed Apr 08, 7:05AM CDT
Robotic medical company Ekso Bionics Holdings (OTCBB:EKSO) disclosed on Wednesday the addition of Amy Wendell to its board of directors.
Amy Wendell Joins Ekso Bionics Board of Directors
GlobeNewswire - Wed Apr 08, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO) today announced that Amy Wendell, former Senior Vice President, Strategy and Business Development of Covidien, global health care products company and manufacturer of medical devices and supplies, has been elected to Ekso Bionics' board of directors.
Ekso Bionics' Rehab Vertical Gets Healthy With Some Big News From The U.K.
Dallas Salazar - at Seeking Alpha - Mon Apr 06, 6:55AM CDT
RWLK: 13.60 (+0.08)
Pivotal Legal Case Settlement Includes Ekso Bionics Ekso GT(TM) Robotic Exoskeleton
Thomson Reuters ONE - Tue Mar 31, 1:00AM CDT
CANARY WHARF, LONDON, March 31, 2015 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that Dale Messenger, who was left paralyzed with an L1 incomplete spinal cord injury after suffering a gunshot wound, settled a long running case at the High Court in the United Kingdom. His damages settlement includes, among other items, the purchase cost of an Ekso Bionics Ekso GT robotic exoskeleton, its replacement over the years, and related utilization costs.
Ekso Bionics: Well-Positioned In A Thriving Industry
Simple Investment Ideas - at Seeking Alpha - Fri Mar 27, 8:07AM CDT
Ekso Bionics: Sales Progress And Improved Financials
Dallas Salazar - at Seeking Alpha - Wed Mar 18, 3:11PM CDT
Ekso Bionics Holdings reports Q4 results
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:15PM CDT
Ekso Bionics Reports Fourth Quarter and 2014 Financial Results
GlobeNewswire - Tue Mar 17, 3:05PM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the quarter and year ended December 31, 2014, as well as recent highlights.
Ekso Bionics(TM) to Host Fourth Quarter and Year End Financial Results Conference Call on Tuesday, March 17th, 2015
GlobeNewswire - Wed Mar 11, 6:00AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company today announced that it will host a conference call and audio webcast to discuss fourth quarter and year end results, as well as provide a general business update, on Tuesday, March 17th, 2015 at 4:30pm ET.
IPO Lockup Expiration: ReWalk Robotics Ltd.
Don Dion - at Seeking Alpha - Tue Mar 03, 7:18AM CST
PH: 120.53 (+0.76), RWLK: 13.60 (+0.08)
Exoskeletons Becoming Science Fact With Potential Opportunity For Early Investors
Investment Capitalist - at Seeking Alpha - Fri Feb 13, 11:37AM CST
ISRG: 530.36 (+17.27), GOOG: 540.01 (-0.77)
ReWalk Robotics Has Been One Painful Science Experiment For Investors
Dallas Salazar - at Seeking Alpha - Thu Feb 12, 11:09PM CST
RWLK: 13.60 (+0.08)
Research and Markets: Global Exoskeleton System Market 2015-2019: Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics
Business Wire - Wed Feb 11, 3:01PM CST
Research and Markets (http://www.researchandmarkets.com/research/rh4pd7/global) has announced the addition of the "Global Exoskeleton System Market 2015-2019" report to their offering.
RWLK: 13.60 (+0.08)
Global Exoskeleton System Market 2015-2019: Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics
M2 - Wed Feb 11, 2:32PM CST
Research and Markets (http://www.researchandmarkets.com/research/5n9pd6/global) has announced the addition of the "Global Exoskeleton System Market 2015-2019" report to their offering. The Global Exoskeleton System market to grow at a CAGR of 72.51% over the period 2014-2019 An exoskeleton system is a man-machine system that combines human intelligence and machine power, thereby enabling individuals to gain super strength to walk or move. It is widely used across the Healthcare sector for rehabilitation. In rehabilitation centers, an exoskeleton system helps in tendon therapy and exercise. Individuals suffering from hip or knee conditions can use exoskeleton system to prevent common accidents such as slipping or to walk again. These systems are also used across the Military and Industrial sectors. One of the major trends in the market is the development of an exoskeleton-mounted computer system for soldiers. The US military has awarded several exoskeleton R&D project contracts to various robotic companies and research institutes in the Americas. According to the report, the rise in orthopedic disorders is a major growth driver for the market. The use of exoskeletons by people with orthopedic disorders helps improve their mobility because they put the body in an upright position, thereby bringing back their self-esteem. Further, the report states that one of the major challenges that the market faces is the high price of exoskeleton systems, which means that they are not affordable for many paralyzed individuals in the developing countries. Several paralyzed individuals in the developing countries cannot afford to buy exoskeletons because insurance companies do not provide funds to buy such devices. Key Vendors - Cyberdyne - Ekso Bionics - ReWalk Robotics - Rex Bionics Other Prominent Vendors - Berkley Robotics - Focal Meditech - Hocoma - Honda - Interactive Motion Technologies - LockHeed Martin - Myomo - Parker Hannafin - Raytheon Sarcos For more information visit http://www.researchandmarkets.com/research/5n9pd6/global
RTN: 109.96 (-0.05), RWLK: 13.60 (+0.08)
Global Exoskeleton System Market 2015-2019 with Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics Dominating
PR Newswire Europe - Wed Feb 11, 12:32PM CST
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets
RWLK: 13.60 (+0.08)
Ekso Bionics(TM) Launches Multi Center Study With Leading European Hospitals
GlobeNewswire - Thu Jan 29, 6:00AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that nine leading centers in Europe including SPZ Notwill in Switzerland, Institut Guttmann in Spain and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark (now part of Rigshospitalet and Glostrup Hospital), are participating in a clinical study to include close to 70 participants. The study will examine how Ekso GT may improve general outcomes as well as reduce secondary complications, such as pain and bowel and bladder dysfunction, commonly associated with spinal cord injury (SCI), and is expected to run for 30 months with early findings expected next year.
Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project
GlobeNewswire - Thu Jan 22, 6:09AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that their leading work on the first phase of the TALOS project resulted in a grant to expand their involvement into the second phase of the project. United States Special Operation Command (SOCOM) announced last year that it was working to create a wearable uniform, which provides superhuman capabilities with superior mobility and protection, for their Special Operations Forces. This project involves four phases, with the second phase to be delivered in the latter part of 2015. With the second phase of the project, this contract marks over $35 million in total third party funded development work done by the Ekso Bionics engineering team.
Research and Markets: Global Rehabilitation Robotics Market 2015-2019 with AlterG, Ekso Bionics, Hocoma & Interactive Motion Technologies Dominating
Business Wire - Fri Jan 09, 5:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/6flkmd/global) has announced the addition of the "Global Rehabilitation Robotics Market 2015-2019" report to their offering.
Global Rehabilitation Robotics Market 2015-2019 with AlterG, Ekso Bionics, Hocoma & Interactive Motion Technologies Dominating
M2 - Fri Jan 09, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/5l5dxp/global) has announced the addition of the "Global Rehabilitation Robotics Market 2015-2019" report to their offering. The analysts forecast the Global Rehabilitation Robotics market to grow at a CAGR of 24.27% over the period 2014-2019 Rehabilitation robots play an important role in improving a patient's functional recovery. Stroke is a global problem, and it is the main cause of disability in most western countries. Rehabilitation robots are used as therapy aids and the potential benefit of robotic therapy is that it can treat a larger number of patients under the supervision of a single therapist. In other words, rehabilitation robots work as a therapeutic tool for optimizing and maximizing clinical effectiveness of a therapy. One major trend emerging in this market is the rise in the number of well-equipped private hospitals with advanced facilities. Private hospitals are well-equipped and provide more advanced facilities compared to public hospitals. In addition, patients can avail the best treatment in private hospitals. According to the report, one of the major drivers of this market is the increase in incidence of orthopedic disorders that cause severe long-term pain and physical disability. Orthopedic disorders affect hundreds of millions of people worldwide. Further, the report states that one of the main challenges in the market is the high cost of rehabilitation robots, which forces patients to opt for normal therapeutic exercises. Moreover, governments are providing decreased reimbursements for rehabilitation robotic therapy. The Global Rehabilitation Robotics market can be segmented into the following based on products: - Prosthetics Robotics - Orthotics Robotics - Therapeutic Robots - Exoskeleton Robotic Systems Key Vendors - AlterG - Ekso Bionics - Hocoma - Interactive Motion Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/5l5dxp/global
